Abstract:
The disclosure relates to methods of diagnosing and treating autism. The disclosure provides diagnostic methods based on identifying alterations in the AUTS2 gene, in particular in the AUTS2 short isoform. The disclosure further relates to therapeutic interventions utilizing the newly identified alternative transcript.